Relationship between iron replacement and hepatic functions in hepatitis C virus-positive chronic haemodialysis patients


ÖZDEMİR A., Yalinbaş B., Selamet U., Eres M., Murat B., Gürsu R. U., ...Daha Fazla

Nephrology, cilt.10, sa.5, ss.433-437, 2005 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 10 Sayı: 5
  • Basım Tarihi: 2005
  • Doi Numarası: 10.1111/j.1440-1797.2005.00474.x
  • Dergi Adı: Nephrology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.433-437
  • Anahtar Kelimeler: hepatocellular injury, iron replacement
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Aim: To investigate the effects of intravenous (i.v.) iron replacement on hepatic functions of hepatitis C virus (HCV)-positive haemodialysis patients. Methods: The present retrospective study included 89 HCV-positive and 57 HCV-negative haemodialysis patients. Alanine aminotransferase (ALT) levels were accepted as sustained high if the last three values were ≥20 U/L. All patients and the HCV-positive group were dichotomised into subgroups by the median for dialysis duration, the amounts of i.v. iron administered per year and totally. Results: Sustained high levels of ALT were significantly more frequent in the HCV-positive group (P < 0.001). In HCV-positive patients, the subgroup with ALT levels ≥20 U/L had significantly higher serum iron levels and mean amounts of i.v. iron administered per year and totally (P < 0.001) and the subgroup with the high mean total amount of i.v. iron had significantly higher serum ALT and iron levels (P < 0.001). Significant positive correlations were found in HCV-positive patients between ALT and serum iron levels (P < 0.001), as well as between ALT both with the mean amounts of i.v. iron administered per year (P = 0006) and totally (P = 0.015). Regression analysis showed that the main parameters effecting ALT were the serum iron level (P < 0.0001) and the mean amount of parenteral iron administered per year (P = 0.032). Conclusion: We conclude that parenteral iron replacement might contribute to hepatocellular injury in HCV-positive haemodialysis patients. © 2005 Asian Pacific Society of Nephrology.